CLINICAL_TRIALS
trial_result
· 2018-12-04
Clinical Trial Update: The EVICEL® Neurosurgery Phase III Study [Phase 3]
Summary
Phase III study update for EVICEL in neurosurgery completed; results were posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ethicon, Inc. | Conditions: Cerebrospinal Fluid Leak | Phase 3 | Status: COMPLETED | Results posted: 2018-12-04